Usdtl
1 known investors
United States Drug Testing Laboratories (USDTL) is a forensic drug testing laboratory offering standard and customized drug screening panels. It is accredited by the College of American Pathologists.
Investors · 1
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $250.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $640.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $162.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2009 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $157.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $109.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2006 | $680.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2006 | $107.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $100K |
| Department of Health and Human Services | Phase I | 1997 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.